HK1060136A1 - Human cervical cance suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector - Google Patents

Human cervical cance suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector

Info

Publication number
HK1060136A1
HK1060136A1 HK04102793A HK04102793A HK1060136A1 HK 1060136 A1 HK1060136 A1 HK 1060136A1 HK 04102793 A HK04102793 A HK 04102793A HK 04102793 A HK04102793 A HK 04102793A HK 1060136 A1 HK1060136 A1 HK 1060136A1
Authority
HK
Hong Kong
Prior art keywords
polynucleotide
protein
expression vector
cancer cell
cance
Prior art date
Application number
HK04102793A
Other languages
English (en)
Inventor
Jin-Woo Kim
Original Assignee
Kim Jin Woo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kim Jin Woo filed Critical Kim Jin Woo
Publication of HK1060136A1 publication Critical patent/HK1060136A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
HK04102793A 2000-04-25 2004-04-21 Human cervical cance suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector HK1060136A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2000-0021897A KR100426455B1 (ko) 2000-04-25 2000-04-25 인간 암 억제 유전자, 이에 의해 코딩되는 단백질, 이를포함하는 발현 벡터 및 이 벡터로 형질전환된 세포
PCT/KR2000/001406 WO2001081387A1 (en) 2000-04-25 2000-12-04 Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector

Publications (1)

Publication Number Publication Date
HK1060136A1 true HK1060136A1 (en) 2004-07-30

Family

ID=36251014

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04102793A HK1060136A1 (en) 2000-04-25 2004-04-21 Human cervical cance suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector

Country Status (11)

Country Link
US (1) US6977296B2 (ko)
EP (1) EP1282641B1 (ko)
JP (1) JP3749182B2 (ko)
KR (1) KR100426455B1 (ko)
CN (1) CN1216909C (ko)
AT (1) ATE325812T1 (ko)
AU (1) AU2001220255A1 (ko)
CA (1) CA2405983A1 (ko)
DE (1) DE60027928T2 (ko)
HK (1) HK1060136A1 (ko)
WO (1) WO2001081387A1 (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100426452B1 (ko) * 2001-01-02 2004-04-13 김진우 인간 원암 유전자로 형질전환된 포유동물 및 이 유전자를이용한 유방암, 신장암, 난소암 또는 위암 진단용 키트
ES2230502T3 (es) * 2001-04-23 2005-05-01 Amaxa Gmbh Disolucion tampon para la electroporacion y procedimiento que incluye el uso de la misma.
KR100434591B1 (ko) * 2002-04-16 2004-06-04 김진우 인간 암 억제 유전자, 이에 의해 코딩되는 단백질, 이를포함하는 발현 벡터 및 이 벡터로 형질전환된 세포
KR100664589B1 (ko) * 2004-12-28 2007-01-04 김현기 인간 암 억제 유전자, 이에 의해 코딩되는 단백질, 및이를 포함하는 발현 벡터
CN105061580B (zh) * 2006-10-03 2020-06-05 罗格斯新泽西州立大学 多肽和药物组合物及其应用
KR101815322B1 (ko) * 2010-01-12 2018-01-05 서울대학교산학협력단 항암 펩타이드 서열

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960034413A (ko) * 1995-03-24 1996-10-22 권계홍 아폽토시스 조절 유전자
AU1873097A (en) * 1996-02-14 1997-09-02 New England Deaconess Hospital Corporation Gene therapy of entothelial cells with anti-apoptotic proteins for transplantation and inflammatory conditions
JP2002516099A (ja) * 1998-05-28 2002-06-04 インサイト・ファーマスーティカルズ・インコーポレイテッド 腫瘍サプレッサー
CA2296792A1 (en) * 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins

Also Published As

Publication number Publication date
EP1282641B1 (en) 2006-05-10
EP1282641A4 (en) 2004-05-19
CN1216909C (zh) 2005-08-31
KR100426455B1 (ko) 2004-04-13
JP3749182B2 (ja) 2006-02-22
EP1282641A1 (en) 2003-02-12
CA2405983A1 (en) 2001-11-01
US20040086974A1 (en) 2004-05-06
US6977296B2 (en) 2005-12-20
DE60027928D1 (de) 2006-06-14
ATE325812T1 (de) 2006-06-15
AU2001220255A1 (en) 2001-11-07
DE60027928T2 (de) 2007-01-04
KR20010097640A (ko) 2001-11-08
WO2001081387A1 (en) 2001-11-01
CN1451016A (zh) 2003-10-22
JP2003534783A (ja) 2003-11-25

Similar Documents

Publication Publication Date Title
IL161591A (en) Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
MXPA02011303A (es) Nueva composicion farmaceutica.
AU3368497A (en) Human dnase i hyperactive variants
CY1109463T1 (el) Πεπτιδια kdr και εμβολια που τα περιλαμβανουν
ATE397621T1 (de) Hemmer der interaktion zwischen p53 und mdm2
MXPA02012272A (es) Compuestos heterociclicos que son inhibidores de la enzima dipeptidilpeptidasa-iv.
NZ515964A (en) A method for the prophylaxis and/or treatment of medical disorders
UA65561A (en) Therapeutic agent for lymphatic tumors
EP1178988A4 (en) THERAPEUTIC COMPOUNDS AND METHODS
NZ596981A (en) Compositions and methods for the treatment of tumor of hematopoietic origin
EP1012189A4 (en) OBESITY TREATMENT
EP2114431A4 (en) ARAZYME-CONTAINING COMPOSITION FOR THE PREVENTION AND TREATMENT OF CANCER
BG106008A (en) Novel lhrh antagonists with improved solubility characteristics
MXPA05010575A (es) Peptacuerpo para el tratamiento del cancer.
CA2432971A1 (en) Polypeptides
HK1060136A1 (en) Human cervical cance suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector
MY125980A (en) Highly purified cytokine activating factor and methods of use
CA2449284A1 (en) Alpha-fetoprotein peptides and uses thereof
HK1053053A1 (en) Use of retinoid receptor antagonists or agonists in the treatment of cartilage and bone pathologies.
MXPA02009781A (es) Isoformas de esfingosina cinasa tipo 2 de mamifero, clonacion, expresion y metodos de uso de las mismas.
AU8811298A (en) Novel peptides and polypeptides useful for regenerating the nervous system
UA83989C2 (ru) Выделенный пептид, который стимулирует противоопухолевый иммунный ответ, фармацевтическая композиция на его основе и ее применение
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
AU2002365974A8 (en) Alpha-fetoprotein peptides and uses thereof
TW200517125A (en) Pharmaceutical composition for treatment of solid cancers

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20101204